Volume 7: Medicines and Cosmetics
Index

A

Abattoir Owners Association

abomasum  2

Abridged Licensing unit  2,  3

accountability

ACDP seeAdvisory Committee on Dangerous Pathogens

Acheson, Sir Donald  2,  3,  4,  5,  6,  7,  8,  9,  10

Active Implantable Medical Devices (Amendment and Transitional Provisions) Regulations 1995

Active Implantable Medical Devices Directive 90/385/EEC

Active Implantable Medical Devices Regulations 1992 SI 1992/3146

active implants

active ingredients

ACVO see Assistant Chief Veterinary Officer

Adams, Dr  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20,  21,  22,  23

adhesives

ADR see Adverse Drug Reaction

adrenal gland  2,  3

ADROIT see Adverse Drug Reactions On-Line Information Tracking

Adverse Drug Reaction (ADR)  2,  3

Adverse Drug Reactions On-Line Information Tracking (ADROIT) database  2

adverse reactions

adverse reactions, reporting of  2

Advisory Committee on Dangerous Pathogens (ACDP)

AFRC see Agriculture and Food Research Council

Agriculture and Food Research Council (AFRC)

Agriculture Ministers

Agriculture Select Committee  2,  3,  4

Agriculture Select Committee, Question and Answer briefing

AHVG see Animal Health Veterinary Group

Ainsworth, Miss

albumin

Alder, Mr Roy

Alderman, Mrs  2,  3

allergens  2,  3,  4,  5,  6,  7

Almond, Professor

alternative sources of bovine material

alternatives to use of bovine material

amniotic fluid

Andrews, Mr  2,  3,  4,  5,  6,  7,  8

Andrews, Mr Derek  2,  3,  4,  5

Animal Health Directorate

Animal Health Division  2,  3,  4,  5,  6,  7

Animal Health Division, consideration of SBO ban

Animal Health Division, policy development on BSE

Animal Health Veterinary Group  2,  3

animal materials, use prior to BSE

Animal Medicines Division  2,  3,  4

Animal Test Certificates (ATC)  2

Animal Test Exemptions

anti-ageing creams  2,  3,  4,  5

antibiotics in feedstuffs

anti-wrinkle creams

appropriately certified healthy herds

aprotinin  2

Armour, Professor  2

Armstrong, Mr  2,  3

artificial insemination

Asscher, Professor  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14

Asscher, Professor, statement of

Assistant Chief Veterinary Officer (ACVO)  2

ATC see animal test certificate

Attridge, Mrs  2

audit of manufacturers

audit of uses of cattle tissues

audit of uses of cattle tissues, adequacy of response

audit of uses of cattle tissues, ambivalent status of project

audit of uses of cattle tissues, by MAFF

audit of uses of cattle tissues, early consideration

audit of uses of cattle tissues, enquiries about

audit of uses of cattle tissues, funding problems

audit of uses of cattle tissues, lack of ownership

audit of uses of cattle tissues, linking with cosmetics

audit of uses of cattle tissues, need for  2

audit of uses of cattle tissues, need for urgency

audit of uses of cattle tissues, priority of

audit of uses of cattle tissues, reasons for

Australasia

Australia  2

Australia, as safe source of BSE-free herds  2,  3

Australia, as source of catgut

autoclaving  2,  3,  4,  5,  6,  7,  8

B

BABS see born after the ban

baby food

bacteria

bacterial cells

bacteriological media

Badenoch, Professor Sir John

Bakar, Mrs E

Baker, Dr H  2

Baker, Mr Keith  2

Baker, Mr Lewis  2,  3,  4

Baker, Mrs Marilyn  2

Barnes, Dr  2,  3

Batho, Mr  2

BC see Biologicals Committee

Beale, Dr

Beale, Dr A

Bean, Mr C

Beechams  2

beef muscle in diphtheria vaccine

Berry, Professor  2,  3

best practice  2,  3,  4,  5,  6

Bewley, Mr

BGA see German Federal Health Office

bile  2,  3,  4

bile, use of controlled source

Biological and Biotechnological Unit

Biological Products and Standards Department (BP&S)  2,  3,  4

Biological Standards Act 1975

Biologicals and recombinant products team, VMD

Biologicals Committee (BC)  2,  3,  4,  5,  6,  7,  8,  9,  10,  11

Biologicals Sub-Committee (BSC)  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17

Biologicals Sub-Committee (BSC), discussion of Sloggem paper

Biologicals Unit  2

Bio-Medical Systems

Biotechnology Working Party (BWP)  2

Biotechnology Working Party (BWP), finalisation of European guidelines

bladder  2

blood  2,  3,  4,  5

blood products  2

Blue Pages  2

bone  2,  3

bone grafts  2

boners

born after the ban (BABS)

Bottomley, Mrs Virginia

Bourne, Professor

bovine anti-serum

bovine insulin  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13

bovine material in medicines  2,  3,  4,  5,  6

bovine material in medicines, audit of uses  2,  3

bovine material in medicines, vaccines

bovine milk derivatives

bovine nutrient broth  2,  3

Bovine Offal (Prohibition) (Amendment) Regulations 1992

Bovine Offal (Prohibition) (Scotland) Regulations 1990

Bovine Offal (Prohibition) Regulations (Northern Ireland) 1990

Bovine Offal (Prohibition) Regulations 1989  2,  3,  4

bovine pericardial implant  2,  3,  4,  5,  6

bovine serum  2

bovine serum albumin (BSA)  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20

bovine soup stock

Bovine Specified Offal ban see also Bovine Offal (Prohibition) Regulations 1989

bovine spongiform encephalopathy (BSE)

bovine spongiform encephalopathy (BSE), as notifiable disease

bovine spongiform encephalopathy (BSE), cattle-to-cattle transmission

bovine spongiform encephalopathy (BSE), epidemiology

bovine spongiform encephalopathy (BSE), implications for biological products

bovine spongiform encephalopathy (BSE), in France  2

bovine spongiform encephalopathy (BSE), in Switzerland  2

bovine spongiform encephalopathy (BSE), incidence of

bovine spongiform encephalopathy (BSE), infectivity of  2

bovine spongiform encephalopathy (BSE), no evidence for risk to humans

bovine spongiform encephalopathy (BSE), options to deal with

bovine spongiform encephalopathy (BSE), perception as animal health problem

bovine spongiform encephalopathy (BSE), removal from tissue extracts

bovine spongiform encephalopathy (BSE), restriction to British Isles

bovine spongiform encephalopathy (BSE), risk from gelatin

bovine spongiform encephalopathy (BSE), scrapie-like nature of

bovine spongiform encephalopathy (BSE), transmission from scrapie-infected sheep

bovine spongiform encephalopathy (BSE), transmission through vaccines

bovine spongiform encephalopathy (BSE), transmission to pig  2

bovine spongiform encephalopathy (BSE), vertical transmission

Bovulin vaccine

Boyd, Dr  2

BP&S see Biological Products and Standards Department

Bradley, Mr  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20,  21,  22,  23,  24,  25,  26,  27,  28,  29,  30,  31,  32

brain  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20,  21,  22,  23,  24,  25,  26,  27,  28

brain heart infusion broth

brain infusion broths

brain, bovine  2

brain, calf  2

brain, horse

brain, in gelatine manufacture

brain, infectivity of

brain, products derived from

brain, sheep  2

brain-penetrative stunning  2,  3,  4,  5,  6,  7,  8,  9,  10

Briefing on Human Medicines

British Diabetic Association  2

Brown, Dr Kate  2,  3,  4,  5,  6

Brown, Mr

BSA see bovine serum albumin

BSC see Biologicals Sub-Committee

BSE see bovine spongiform encephalopathy

BSE Working Group  2,  3,  4,  5,  6,  7,  8,  9

BSE Working Group, advice to CSDM and CSM

BSE Working Group, CDSM endorsement of recommendations

BSE Working Group, consideration of cosmetics

BSE Working Group, consideration of risks by

BSE Working Group, CSM endorsement of recommendations  2

BSE Working Group, fifth meeting

BSE Working Group, first meeting  2

BSE Working Group, fourth meeting  2

BSE Working Group, inconsistency of advice with SBO ban

BSE Working Group, people attending

BSE Working Group, perception of remote risk to humans

BSE Working Group, proposal for further meeting

BSE Working Group, role in human medicines

BSE Working Group, second meeting

BSE Working Group, see also Southwood Working Party

BSE Working Group, third meeting  2

BSE Working Group, views on medical devices

BSE Working Party, need for continued involvement

BSE-related pharmaceuticals research

BSEWG see BSE Working Group

buffy coat

Burton, Mr Will  2,  3,  4,  5,  6,  7,  8,  9,  10,  11,  12,  13,  14,  15,  16,  17,  18,  19,  20,  21

Burton, Mr Will, response to Dr Pickles

Burton, Mr Will, STD BSE working party

Business Groups, of MCA  2

butchers

butchers, CJD not observed in

butchers, scrapie not transmitted to

BWP see Biotechnology Working Party

by-products of bovine slaughter